AGEX THERAPEUTICS INC (AGE)
US00848H2076 - Common Stock
AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results
ALAMEDA, Calif., March 22, 2024 (GLOBE NEWSWIRE) -- AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics...
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates AGE, GRPH, FIXX
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are a hot topic on Thursday morning and we have all the coverage traders need to know about today.
AgeX Therapeutics Reports Third Quarter 2023 Financial Results
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NXGN, SMMF, RPT, AGE
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SMMF, RPT, AGE
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AGE, NXGN, AVTA, SPLK
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVID, SMMF, RPT, AGE
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NXGN, RPT, THRN, AGE
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ABCM, AGE, ACER, NXGN
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WRK, AGE, ACER
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates THRN, ABCM, AGE, ACER
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
AGE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of AgeX Therapeutics, Inc. Is Fair to Shareholders
Serina Therapeutics and Agex Therapeutics enter merger agreement (NYSE:AGE)
Serina Therapeutics on Wednesday said it would merge with a wholly-owned subsidiary of AgeX Therapeutics (AGE) in an all-stock transaction.The combined company will focus on...
Serina Therapeutics and AgeX Therapeutics Enter into Merger Agreement
AgeX Therapeutics Reports Second Quarter 2023 Financial Results
AgeX Therapeutics Closes $36,000,000 Debt Exchange for Preferred Stock
AgeX issues preferred stock to Juvenescence to nix $36M debt (NYSE:AGE)
AgeX Therapeutics (AGE) said Friday it entered into a shares-for-debt exchange agreement with Juvenescence Limited
AgeX Therapeutics Announces $36,000,000 Debt Exchange for Preferred Stock
AgeX Therapeutics Announces Appeal of NYSE American Determination
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time to start off the final day of the trading week with a breakdown of the biggest pre-market stock movers for Friday!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to start the day with a breakdown of all the biggest pre-market stock movers worth reading about on Thursday!
AgeX Therapeutics Reports First Quarter 2023 Financial Results
AgeX Therapeutics Receives Stock Exchange Deficiency Letter
AgeX Therapeutics Reports Fourth Quarter and Annual 2022 Financial Results
AGE stock gains after getting $10M loan for restructuring (NYSE:AGE)
AgeX Therapeutics (AGE), a biotech focused on human aging, announced that Juvenescence Limited provided the company with a $10M loan ahead of a planned restructuring program.
AgeX Therapeutics Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing Requirements
AgeX Therapeutics Reports Third Quarter 2022 Financial Results
AgeX Therapeutics Reports Second Quarter 2022 Financial Results
Dr. Joanne Hackett Appointed Chairperson of AgeX Board of Directors
